Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 2/20 | 0.54 |
| ▸ | FDPS | P14324 | 3/20 | 0.50 |
| ▸ | LAP3 | P28838 | 3/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27964000 | 1.00 | METAP1 (0.54) | METAP1FDPSLAP3S1PR2S1PR1 | |
| Butanone SCHEMBL27921958 | 0.89 | METAP1 (0.50) | METAP1FDPSLAP3S1PR2S1PR1 | |
| Butanone SCHEMBL28000522 | 0.89 | METAP1 (0.50) | METAP1FDPSLAP3S1PR2S1PR1 | |
| SCHEMBL14964219 | 0.86 | — | — | |
| SCHEMBL133123 | 0.86 | — | — | |
| SCHEMBL28944007 | 0.86 | — | — | |
| Phosphoric Acid SCHEMBL5053808 | 0.83 | LAP3 (0.63) | FDPSLAP3S1PR2S1PR1S1PR3 | |
| Butane SCHEMBL9870581 | 0.83 | METAP1 (0.39) | METAP1FDPSALDH1A1TDP1 | |
| SCHEMBL8570780 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL9221283 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106979-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GEVO, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260132429-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GEVO INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260015633-A1 | PROCESS FOR PRODUCTION OF ALCOHOLS FROM CELL LYSATE | GEVO INC (US) | 2026-01-15 | — | — | US | disclosed |
| CN-105229156-A | For utilizing the method extracting fermentative production butanols | BUTAMAX TM ADVANCED BIOFUELS | 2016-01-06 | — | — | CN | disclosed |
| WO-2015103002-A1 | ISOBUTANOL TOLERANCE IN YEAST WITH AN ALTERED LIPID PROFILE | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-07-09 | — | — | WO | disclosed |
| US-8980612-B2 | Fermentive production of four carbon alcohols | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-03-17 | — | — | US | disclosed |
| US-8962298-B2 | Recombinant host cell comprising a diol dehydratase | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-02-24 | — | — | US | disclosed |
| WO-2015009601-A1 | YEAST WITH INCREASED BUTANOL TOLERANCE INVOLVING CELL WALL PROTEINS | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-01-22 | — | — | WO | disclosed |
| CN-104284980-A | Gene switch for butanol production | BUTAMAX TM ADVANCED BIOFUELS | 2015-01-14 | — | — | CN | disclosed |
| WO-2015002916-A1 | POST-TRANSCRIPTIONAL REGULATION OF BIOSYNTHETIC PATHWAYS | BUTAMAX ADVANCED BIOFUELS LLC (US) | 2015-01-08 | — | — | WO | disclosed |
| EP-2010643-A2 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-01-07 | — | — | EP | disclosed |
| EP-2010664-A2 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-01-07 | — | — | EP | disclosed |
| WO-2008137403-A1 | METHOD FOR THE PRODUCTION OF 2-BUTANOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137404-A1 | METHOD FOR THE PRODUCTION OF 2-BUTANONE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-13 | — | — | WO | disclosed |
| US-20080274525-A1 | METHOD FOR THE PRODUCTION OF 2-BUTANOL | GEVO, INC. | 2008-11-06 | — | — | US | disclosed |
| US-20080274522-A1 | METHOD FOR THE PRODUCTION OF 2-BUTANONE | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-11-06 | — | — | US | disclosed |
| US-20070292927-A1 | producing 2-butanol and 2-butanone by the fermentive growth of a recombinant bacteria expressing a 2-butanol biosynthetic pathway | GEVO, INC. | 2007-12-20 | — | — | US | disclosed |
| WO-2007130521-A2 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-15 | — | — | WO | disclosed |
| WO-2007130518-A2 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-15 | — | — | WO | disclosed |
| US-20070259410-A1 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | GEVO, INC. | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132429-A1 | PROCESSES AND SYSTEMS FOR FERMENTATIVE ALCOHOL PRODUCTION AND RECOVERY | GK, ADH1C, ADH5 | METAP1 4805/4885FDPS 253/4885LAP3 3616/4885 |
| US-20260015633-A1 | PROCESS FOR PRODUCTION OF ALCOHOLS FROM CELL LYSATE | SORD, ADH1C, ADH5 | METAP1 4697/4885FDPS 1453/4885LAP3 2696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.